黄素对非小细胞肺癌的机制:基于网络药理学,分子对接,分子动力学模拟和体外实验的研究
Jihang Zhang1,2, Changling Li3, Wenyi Li1
1The First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.
Frontiers in oncology
|November 25, 2024
概括
丁醇对非小细胞肺癌 (NSCLC) 具有抗癌作用. 它通过诱导亡来抑制NSCLC细胞生长和迁移,可能通过Akt/MDM2/p53信号通路.
科学领域:
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
- 计算生物学 计算生物学
背景情况:
- 素是一种天然的黄类化合物,具有潜在的抗癌特性.
- 黄素对非小细胞肺癌 (NSCLC) 的精确抗癌机制尚未完全理解.
研究的目的:
- 通过多方方法调查黄素对NSCLC的分子机制.
- 为了确定关键的标和信号通路,参与luteolin的抗NSCLC活动.
主要方法:
- 网络药理学用于识别黄素和NSCLC的标.
- 蛋白与蛋白相互作用 (PPI) 网络分析,基因本体学 (GO) 和基因和基因组 (KEGG) 丰富的京都百科全书.
- 分子对接,分子动力学模拟 (MDS) 和使用A549细胞进行体外验证.
主要成果:
- 确定了六个核心目标 (TP53,EGFR,AKT1,TNF,JUN,CASP3) 和关键途径 (PI3K-Akt,NF-kappa B).
- 氨酸与核心标具有很高的结合亲和力,与TP53和AKT1.1具有稳定的相互作用.
- 在体外,黄素抑制了NSCLC细胞的增殖和迁移,诱导了亡,并调节了关键蛋白表达 (p53,Bax,p-Akt,MDM2,Bcl-2).
结论:
- 素具有显著的抗NSCLC作用.
- 素诱导的亡可能是通过Akt/MDM2/p53信号通路进行的.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Ligand Binding Sites
12.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.7K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K


